Dyskinesia and adherence to safinamide and opicapone in fluctuating patients with Parkinson's disease: observational retrospective study

被引：0
|
作者：
Lorenzo-Barreto, P.
Parees, I.
Perez-Torre, P.
Fanjul, S.
Lopez-Sendon, J. L.
Perez-Trapote, F.
Saez-Marin, A.
Stiauren-Fernandez, E.
Patino-Paton, A.
Martinez-Castrillo, J. C.
Alonso-Canovas, A.
机构：
来源：
MOVEMENT DISORDERS | 2023年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
1409
引用
收藏
页码：S614 / S615
页数：2
相关论文
共 50 条
  • [41] Impact of SAfinamide on Depressive Symptoms in Parkinson's Disease Patients (SADness-PD Study): A Multicenter Retrospective Study
    Pena, Esteban
    Borrue, Carmen
    Mata, Marina
    Carlos Martinez-Castrillo, Juan
    Alonso-Canovas, Araceli
    Luis Chico, Juan
    Lopez-Manzanares, Lydia
    Llanero, Marcos
    Herreros-Rodriguez, Jaime
    Esquivel, Alberto
    Maycas-Cepeda, Teresa
    Ruiz-Huete, Cristina
    BRAIN SCIENCES, 2021, 11 (02) : 1 - 11
  • [42] Effectiveness of opicapone and switching from entacapone in fluctuating Parkinson disease
    Ferreira, Joaquim J.
    Lees, Andrew J.
    Poewe, Werner
    Rascol, Olivier
    Rocha, Jose-Francisco
    Keller, Birgit
    Soares-da-Silva, Patricio
    NEUROLOGY, 2018, 90 (21) : E1849 - E1857
  • [43] Hepatic safety of opicapone in Parkinson's disease patients
    Lopes, N.
    Ferreira, J.
    Lees, A.
    Gama, H.
    Santos, A.
    Oliveira, C.
    Costa, R.
    Nunes, T.
    Rocha, J. F.
    Soares-da-Silva, P.
    MOVEMENT DISORDERS, 2015, 30 : S101 - S101
  • [44] Long-Term Efficacy of Safinamide on Symptoms Severity and Quality of Life in Fluctuating Parkinson's Disease Patients
    Cattaneo, Carlo
    Jost, Wolfgang H.
    Bonizzoni, Erminio
    JOURNAL OF PARKINSONS DISEASE, 2020, 10 (01) : 89 - 97
  • [45] Safinamide for pain management in patients with Parkinson's disease
    Abilashimova, D.
    Aubakirova, M.
    Abdildin, Y.
    Viderman, D.
    REVUE NEUROLOGIQUE, 2025, 181 (1-2) : 11 - 20
  • [46] Effects of safinamide in patients with Parkinson's disease measured by Parkinson's KinetiGraphTM
    Suttrup, I.
    Zentsch, V.
    Schroeder, J.
    Warnecke, T.
    MOVEMENT DISORDERS, 2016, 31 : S623 - S623
  • [47] Opicapone Effect on Sleep Disorders in Fluctuating Parkinson's disease (PD) Patients: Findings from the OASIS Trial
    Ferreira, J.
    Gago, M.
    Costa, R.
    Fonesca, M.
    Almeida, J.
    Rocha, J.
    Holenz, J.
    Trenkwalder, C.
    MOVEMENT DISORDERS, 2024, 39 : S305 - S306
  • [48] OBSERVATIONAL STUDY OF SAFINAMIDE AS AN ADD-ON TO LEVODOPA MONOTHERAPY FOR PARKINSON'S DISEASE PATIENTS WITH WEARING-OFF IN JAPAN
    Nishikawa, N.
    Hatano, T.
    Nishioka, K.
    Ueno, S. -I.
    Saiki, S.
    Nakamura, R.
    Yoritaka, A.
    Ogawa, T.
    Shimo, Y.
    Sako, W.
    Shimura, H.
    Furukawa, Y.
    Kamei, T.
    Ozawa, T.
    Ishida, T.
    Hattori, N.
    PARKINSONISM & RELATED DISORDERS, 2024, 122
  • [49] Effectiveness of opicapone in Parkinson's disease patients with motor fluctuations according to baseline use of safinamide: Findings from the real-world OPTIPARK study
    Pavese, Nicola
    Lees, Andrew
    Reichmann, Heinz
    Martins, Diogo
    Magalhaes, Diogo
    Rocha, Jose
    Soares-Da-Silva, Patricio
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429 : 268 - 269
  • [50] Effectiveness of Opicapone in Parkinson's according to baseline use of safinamide: the real-world OPTIPARK study
    Pavese, N.
    Lees, A.
    Reichmann, H.
    Martins, D.
    Magalhaes, D.
    Rocha, J.
    Soares-da-Silva, P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2021, 28 : 321 - 321
12345